Publications

Bell , S.J., Fam, C.M., Chlipala, E.A., Carlson, S.J., Lee, J.I., Rosendahl, M.S., Doherty, D.H. and Cox, G.N. (2008)
Enhanced circulating half-life and anti-tumor activity of a site-specific pegylated interferon- a protein therapeutic. Bioconjugate Chemistry 19: 299-305.

Cox, G.N., Rosendahl, M.S., Chlipala, E.A., Smith, D.J., Carlson, S.J. and Doherty, D.H. (2007)
A long-acting, monoPEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats. Endocrinology 148: 1590-1597.

Long, D.L., Doherty, D.H., Eisenberg, S.P., Smith, D.J., Rosendahl, M.S., Christensen, K.R., Edwards, D.P., Chlipala, E.A., and Cox, G.N. (2006)
Design of homogeneous, monoPEGylated erythropoietin analogs with preserved in vitro bioactivity. Experimental Hematology 34: 697-704.

Doherty, D.H., Rosendahl, M.S., Smith, D.J., Hughes, J.M., Chlipala, E.A. and Cox, G.N. (2005)
Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor. Bioconjugate Chemistry 16: 1291-1298.

Rosendahl, M.S., Doherty, D.H., Smith, D.J., Bendele, A.M. and Cox, G.N. (2005)
Site-specific protein PEGylation: application to cysteine analogs of recombinant human granulocyte colony-stimulating factor. BioProcess International 3: 52-62.

Rosendahl, M.S., Doherty, D.H., Smith, D.J., Carlson, S.J., Chlipala, E.A. and Cox, G.N. (2005)
A long-acting, highly potent interferon α-2 conjugate created using site-specific PEGylation. Bioconjugate Chemistry 16: 200-207.

Cox, G.N., Smith, D.J., Carlson, S.J., Bendele, A.M., Chlipala, E.A. and Doherty, D.H. (2004)
Enhanced circulating half-life and hematopoietic properties of a human granulocyte colony-stimulating factor (G-CSF)-immunoglobulin fusion protein. Experimental Hematology 32: 441-449.